Sen. Mike Braun (R-IN)(Francis Chung/POLITICO via AP Images)
Lawmakers push for faster, conditional FDA approval pathway for rare disease drugs
As the FDA tightens its focus on rare disease treatments and speeding their entry to market, lawmakers on Capitol Hill are putting serious stock in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
